The SDF-1/CXCR4 axis seems to be a novel therapeutic approach to improve post-infarction therapy by attracting circulating stem cells to the site of injury where they differentiated into cardiac cells in the infarcted heart [27]. The gene discussed is CXCL12; the disease is infarction.